PAVmed (PAVM) Net Cash Flow Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 55.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.32% |
| Sep 30, 2025 | 52.36% |
| Jun 30, 2025 | 45.52% |
| Mar 31, 2025 | 28.45% |
| Dec 31, 2024 | -78.09% |
| Jun 30, 2024 | 80.93% |
| Mar 31, 2024 | -42.67% |
| Dec 31, 2023 | -40.19% |
| Sep 30, 2023 | -121.49% |
| Jun 30, 2023 | -94.33% |
| Mar 31, 2023 | 56.00% |
| Dec 31, 2022 | -115.66% |
| Sep 30, 2022 | -43.85% |
| Jun 30, 2022 | -46.51% |
| Mar 31, 2022 | -45.89% |
| Dec 31, 2021 | 245.26% |
| Sep 30, 2021 | -46.34% |
| Jun 30, 2021 | -39.43% |
| Mar 31, 2021 | 146.24% |
| Dec 31, 2020 | 97.35% |
| Sep 30, 2020 | -26.29% |
| Jun 30, 2020 | -26.09% |
| Mar 31, 2020 | 98.75% |
| Dec 31, 2019 | 55.55% |
| Sep 30, 2019 | -31.57% |
| Jun 30, 2019 | 56.08% |
| Mar 31, 2019 | -96.52% |
| Dec 31, 2018 | -16.30% |
| Sep 30, 2018 | -59.99% |
| Jun 30, 2018 | 236.65% |
| Mar 31, 2018 | 176.21% |